370 related articles for article (PubMed ID: 17102709)
1. A comparative meta-analysis of Clinical Global Impressions change in antidepressant trials.
Spielmans GI; McFall JP
J Nerv Ment Dis; 2006 Nov; 194(11):845-52. PubMed ID: 17102709
[TBL] [Abstract][Full Text] [Related]
2. Pattern analysis of antidepressant response to fluoxetine.
Fieve RR; Goodnick PJ; Peselow ED; Barouche F; Schlegel A
J Clin Psychiatry; 1986 Nov; 47(11):560-2. PubMed ID: 3533909
[TBL] [Abstract][Full Text] [Related]
3. Relationship between depression severity entry criteria and antidepressant clinical trial outcomes.
Khan A; Schwartz K; Kolts RL; Ridgway D; Lineberry C
Biol Psychiatry; 2007 Jul; 62(1):65-71. PubMed ID: 17141744
[TBL] [Abstract][Full Text] [Related]
4. Using longitudinal data from a clinical trial in depression to assess the reliability of its outcome scales.
Laenen A; Alonso A; Molenberghs G; Vangeneugden T; Mallinckrodt CH
J Psychiatr Res; 2009 Apr; 43(7):730-8. PubMed ID: 18986657
[TBL] [Abstract][Full Text] [Related]
5. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the Hamilton Depression Rating Scale and the Montgomery-Asberg Depression Rating Scale in depressed elderly: a meta-analysis.
Heo M; Murphy CF; Meyers BS
Am J Geriatr Psychiatry; 2007 Oct; 15(10):899-905. PubMed ID: 17911366
[TBL] [Abstract][Full Text] [Related]
7. Relative sensitivity of the Montgomery-Asberg Depression Rating Scale, the Hamilton Depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials.
Khan A; Khan SR; Shankles EB; Polissar NL
Int Clin Psychopharmacol; 2002 Nov; 17(6):281-5. PubMed ID: 12409681
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
Septien-Velez L; Pitrosky B; Padmanabhan SK; Germain JM; Tourian KA
Int Clin Psychopharmacol; 2007 Nov; 22(6):338-47. PubMed ID: 17917552
[TBL] [Abstract][Full Text] [Related]
9. Relative sensitivity of the Montgomery-Asberg depression rating scale, the Hamilton depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials: a replication analysis.
Khan A; Brodhead AE; Kolts RL
Int Clin Psychopharmacol; 2004 May; 19(3):157-60. PubMed ID: 15107658
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant treatment of depression in HIV-seropositive women.
Ferrando SJ; Rabkin JG; de Moore GM; Rabkin R
J Clin Psychiatry; 1999 Nov; 60(11):741-6. PubMed ID: 10584761
[TBL] [Abstract][Full Text] [Related]
11. An examination of the sensitivity of the six-item Hamilton Rating Scale for Depression in a sample of patients suffering from major depressive disorder.
Hooper CL; Bakish D
J Psychiatry Neurosci; 2000 Mar; 25(2):178-84. PubMed ID: 10740991
[TBL] [Abstract][Full Text] [Related]
12. Psychometric evaluation of a Patient-Rated Most Troubling Symptom Scale for Depression: findings from a secondary analysis of a clinical trial.
Pandina GJ; Garibaldi GM; Revicki DA; Kleinman L; Turkoz I; Kujawa MJ; Mahmoud RA
Int Clin Psychopharmacol; 2010 Mar; 25(2):51-9. PubMed ID: 20061962
[TBL] [Abstract][Full Text] [Related]
13. Clinical effect of nemifitide, a novel pentapeptide antidepressant, in the treatment of severely depressed refractory patients.
Feighner JP; Sverdlov L; Hlavka J; Nicolau G; Cartwright K; Freed JS
Int Clin Psychopharmacol; 2008 Jan; 23(1):29-35. PubMed ID: 18090505
[TBL] [Abstract][Full Text] [Related]
14. Placebo response and antidepressant clinical trial outcome.
Khan A; Detke M; Khan SR; Mallinckrodt C
J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731
[TBL] [Abstract][Full Text] [Related]
15. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC
J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
[TBL] [Abstract][Full Text] [Related]
17. Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled trial.
Pandina GJ; Revicki DA; Kleinman L; Turkoz I; Wu JH; Kujawa MJ; Mahmoud R; Gharabawi GM
J Affect Disord; 2009 Nov; 118(1-3):139-46. PubMed ID: 19321206
[TBL] [Abstract][Full Text] [Related]
18. Why the Hamilton Depression Rating Scale endures.
Licht RW; Bech P
Am J Psychiatry; 2005 Dec; 162(12):2394-5; author reply 2397-8. PubMed ID: 16330614
[No Abstract] [Full Text] [Related]
19. Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials.
Khan A; Brodhead AE; Kolts RL; Brown WA
J Psychiatr Res; 2005 Mar; 39(2):145-50. PubMed ID: 15589562
[TBL] [Abstract][Full Text] [Related]
20. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
Honig A; Kuyper AM; Schene AH; van Melle JP; de Jonge P; Tulner DM; Schins A; Crijns HJ; Kuijpers PM; Vossen H; Lousberg R; Ormel J;
Psychosom Med; 2007; 69(7):606-13. PubMed ID: 17846258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
